首页 > 最新文献

Journal of Clinical Imaging Science最新文献

英文 中文
A review and perspective on the neural basis of radiological expertise. 对放射学专业知识的神经基础的回顾和展望。
IF 0.9 Q3 Medicine Pub Date : 2023-10-07 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_135_2022
Ryan Juien Chang, Rommy Elyan, Biyar Ahmed, Prasanna Karunanayaka

Radiological expertise requires tremendous time, effort, and training. While there has been a myriad of studies focusing on radiological expertise and error, the precise underlying neural mechanism still remains largely unexplored. In this article, we review potential neural mechanisms, namely, the fusiform face area, working memory, and predictive coding and propose experiments to test the predictive coding framework.

放射专业知识需要大量的时间、精力和培训。尽管已经有无数的研究聚焦于放射学专业知识和误差,但确切的潜在神经机制在很大程度上仍未被探索。在这篇文章中,我们回顾了潜在的神经机制,即纺锤形面部区域、工作记忆和预测编码,并提出了测试预测编码框架的实验。
{"title":"A review and perspective on the neural basis of radiological expertise.","authors":"Ryan Juien Chang, Rommy Elyan, Biyar Ahmed, Prasanna Karunanayaka","doi":"10.25259/JCIS_135_2022","DOIUrl":"10.25259/JCIS_135_2022","url":null,"abstract":"<p><p>Radiological expertise requires tremendous time, effort, and training. While there has been a myriad of studies focusing on radiological expertise and error, the precise underlying neural mechanism still remains largely unexplored. In this article, we review potential neural mechanisms, namely, the fusiform face area, working memory, and predictive coding and propose experiments to test the predictive coding framework.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629248/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Losing vigilance in diagnosing pulmonary alveolar microlithiasis: A report on four cases. 肺泡微石症诊断失警4例报告。
IF 0.9 Q3 Medicine Pub Date : 2023-10-03 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_56_2023
Hoang Van Luong, Lam Viet Anh, Pham Thanh Nguyen

Pulmonary alveolar microlithiasis (PAM) is a rare chronic lung disease characterized by calcium and phosphate deposition in the alveolar lumen throughout the parenchyma of both lungs, with predominance in the middle and lower lung fields. It is caused by mutations in the recessive gene, SLC34A2, on the autosomal chromosome. In this article, we characterize four cases of PAM and analyze the loss of diagnostic vigilance in two of them. Patients came to medical facilities with clinical manifestations such as cough, shortness of breath, chest pain, and fatigue. The initial diagnosis was unclear in two cases because the X-ray film's quality was not good enough and the medical staff had little experience in clinical and chest X-ray interpretations for PAM. The definitive diagnosis was based on a combination of high-resolution computed tomography (CT) and bronchoalveolar lavage fluid testing. In addition, chest X-ray and high-resolution CT enable the assessment of the stage, progression, and severity of the disease. There is currently no specific treatment for PAM other than lung transplantation.

肺泡微石症(PAM)是一种罕见的慢性肺部疾病,其特征是钙和磷酸盐沉积在整个肺实质的肺泡腔中,主要分布在中、下肺野。它是由常染色体上的隐性基因SLC34A2突变引起的。在这篇文章中,我们描述了四例PAM病例,并分析了其中两例的诊断警惕性丧失。患者来到医疗机构时出现咳嗽、呼吸急促、胸痛和疲劳等临床症状。两例病例的初步诊断不清楚,因为X光片的质量不够好,医务人员对PAM的临床和胸部X光解释经验不足。最终诊断是基于高分辨率计算机断层扫描(CT)和支气管肺泡灌洗液测试的结合。此外,胸部X光和高分辨率CT可以评估疾病的分期、进展和严重程度。除肺移植外,目前尚无针对PAM的特异性治疗方法。
{"title":"Losing vigilance in diagnosing pulmonary alveolar microlithiasis: A report on four cases.","authors":"Hoang Van Luong, Lam Viet Anh, Pham Thanh Nguyen","doi":"10.25259/JCIS_56_2023","DOIUrl":"10.25259/JCIS_56_2023","url":null,"abstract":"<p><p>Pulmonary alveolar microlithiasis (PAM) is a rare chronic lung disease characterized by calcium and phosphate deposition in the alveolar lumen throughout the parenchyma of both lungs, with predominance in the middle and lower lung fields. It is caused by mutations in the recessive gene, <i>SLC34A2</i>, on the autosomal chromosome. In this article, we characterize four cases of PAM and analyze the loss of diagnostic vigilance in two of them. Patients came to medical facilities with clinical manifestations such as cough, shortness of breath, chest pain, and fatigue. The initial diagnosis was unclear in two cases because the X-ray film's quality was not good enough and the medical staff had little experience in clinical and chest X-ray interpretations for PAM. The definitive diagnosis was based on a combination of high-resolution computed tomography (CT) and bronchoalveolar lavage fluid testing. In addition, chest X-ray and high-resolution CT enable the assessment of the stage, progression, and severity of the disease. There is currently no specific treatment for PAM other than lung transplantation.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-cell cancer of the perihilar bile duct with bleeding esophageal varices: A report of a rare case. 肝门周围胆管小细胞癌伴食管静脉曲张出血:一例罕见病例报告。
IF 0.9 Q3 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_53_2023
Ho Xuan Tuan, Dau Quang Lieu, Dao-Thi Luan, Nguyen Minh Duc

Small-cell cancer is an uncommon histological subtype of neuroendocrine carcinoma. It frequently has a poor prognosis because of distant metastasis. It is diagnosed using histopathological and immunohistochemical tests. We report the case of a 29-year-old female with small-cell cancer in the perihilar bile duct who presented with bleeding esophageal varices. This case report aims to improve physicians' understanding of small-cell cancer, thereby helping to reduce the frequency of missed clinical diagnoses.

小细胞癌症是一种罕见的神经内分泌癌组织学亚型。由于远处转移,其预后往往较差。通过组织病理学和免疫组织化学测试进行诊断。我们报告了一例29岁女性肝门周围胆管小细胞癌症,并伴有食管静脉曲张出血。本病例报告旨在提高医生对小细胞癌症的认识,从而有助于减少临床漏诊的频率。
{"title":"Small-cell cancer of the perihilar bile duct with bleeding esophageal varices: A report of a rare case.","authors":"Ho Xuan Tuan,&nbsp;Dau Quang Lieu,&nbsp;Dao-Thi Luan,&nbsp;Nguyen Minh Duc","doi":"10.25259/JCIS_53_2023","DOIUrl":"10.25259/JCIS_53_2023","url":null,"abstract":"<p><p>Small-cell cancer is an uncommon histological subtype of neuroendocrine carcinoma. It frequently has a poor prognosis because of distant metastasis. It is diagnosed using histopathological and immunohistochemical tests. We report the case of a 29-year-old female with small-cell cancer in the perihilar bile duct who presented with bleeding esophageal varices. This case report aims to improve physicians' understanding of small-cell cancer, thereby helping to reduce the frequency of missed clinical diagnoses.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a2/61/JCIS-13-30.PMC10559499.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41115433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy. p16阳性口咽癌症的治疗后PET/CT经明确质子治疗。
IF 0.9 Q3 Medicine Pub Date : 2023-09-29 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_74_2023
Gregory S Alexander, Ariel Eve Pollock, Danielle Arons, Matthew J Ferris, Jason K Molitoris, William F Regine, Matthew E Witek

Objectives: Given emerging data suggesting that uncertainty in the relative biologic effectiveness at the distal end of the Bragg peak results in increased mucosal injury in patients with oropharynx cancer receiving adjuvant proton therapy, we evaluated the results of post-treatment positron emission tomography-computed tomography (PET/CT) in patients with p16-positive oropharynx cancer (p16+OPC) treated with definitive intensity-modulated proton therapy (IMPT).

Material and methods: A retrospective cohort study of patients with p16+OPC treated with definitive IMPT between 2016 and 2022 was performed at a single institution. Patients with PET/CT scans within 6 months following completion of IMPT were included in the study. Positive post-treatment scans were defined by a maximum standard uptake values (SUVmax) >4.0 or a <65% reduction in SUVmax in either the primary tumor or lymph node. The Fisher's exact test was used to evaluate factors associated with positive post-treatment PET/ CT values.

Results: Sixty-two patients were included for analysis. Median follow-up was 21 months (range: 3-71 months) with a median time to post-treatment PET/CT of 3 months (range: 2-6 months). Median post-treatment SUVmax of the primary disease and nodal disease was 0 (mean: 0.8, range: 0-7.7) and 0 (mean: 0.7, range: 0-9.5), respectively. Median post-treatment percent reduction in SUVmax for the primary site and lymph node was 100% (mean: 94%, range: 31.3-100%) and 100% (mean: 89%, range: 23-100%), respectively. Eleven patients had a positive post-treatment PET/CT with one biopsy-proven recurrence. Negative and positive predictive values (NPV and PPV) were 98% and 9.1%, respectively. There were no factors associated with positive post-treatment PET/CT.

Conclusion: Similar to patients treated with photon-based radiation therapy, post-treatment PET/CT has a high NPV for patients with p16+OPC treated with definitive proton therapy and should be used to guide patient management. Additional patients and more events are needed to confirm the PPV of a post-treatment PET/CT in this favorable patient cohort.

目的:鉴于新出现的数据表明Bragg峰远端相对生物有效性的不确定性导致接受辅助质子治疗的口咽癌症患者的粘膜损伤增加,我们评估了接受明确强度调制质子治疗(IMPT)的p16阳性口咽癌症(p16+OPC)患者的治疗后正电子发射断层扫描计算机断层扫描(PET/CT)结果。材料和方法:2016年至2022年间,在一家机构对接受明确强度调节质子治疗的p16+OPC患者进行了回顾性队列研究。IMPT完成后6个月内进行PET/CT扫描的患者被纳入研究。治疗后阳性扫描由最大标准摄取值(SUVmax)>4.0或a定义。结果:62名患者被纳入分析。中位随访时间为21个月(范围:3-71个月),治疗后PET/CT的中位时间为3个月(时间范围:2-6个月)。原发性疾病和淋巴结疾病的中位治疗后SUVmax分别为0(平均值:0.8,范围:0-7.7)和0(平均数:0.7,范围:0-9.5)。治疗后原发部位和淋巴结SUVmax的中位降低百分比分别为100%(平均:94%,范围:31.3-100%)和100%(平均值:89%,范围:23-100%)。11例患者治疗后PET/CT呈阳性,其中一例活检证实复发。阴性和阳性预测值(NPV和PPV)分别为98%和9.1%。没有与治疗后阳性PET/CT相关的因素。结论:与接受光子放射治疗的患者类似,接受明确质子治疗的p16+OPC患者的治疗后PET/CT具有较高的NPV,应用于指导患者管理。在这个有利的患者队列中,需要更多的患者和更多的事件来确认治疗后PET/CT的PPV。
{"title":"Post-treatment PET/CT for p16-positive oropharynx cancer treated with definitive proton therapy.","authors":"Gregory S Alexander,&nbsp;Ariel Eve Pollock,&nbsp;Danielle Arons,&nbsp;Matthew J Ferris,&nbsp;Jason K Molitoris,&nbsp;William F Regine,&nbsp;Matthew E Witek","doi":"10.25259/JCIS_74_2023","DOIUrl":"10.25259/JCIS_74_2023","url":null,"abstract":"<p><strong>Objectives: </strong>Given emerging data suggesting that uncertainty in the relative biologic effectiveness at the distal end of the Bragg peak results in increased mucosal injury in patients with oropharynx cancer receiving adjuvant proton therapy, we evaluated the results of post-treatment positron emission tomography-computed tomography (PET/CT) in patients with p16-positive oropharynx cancer (p16+OPC) treated with definitive intensity-modulated proton therapy (IMPT).</p><p><strong>Material and methods: </strong>A retrospective cohort study of patients with p16+OPC treated with definitive IMPT between 2016 and 2022 was performed at a single institution. Patients with PET/CT scans within 6 months following completion of IMPT were included in the study. Positive post-treatment scans were defined by a maximum standard uptake values (SUVmax) >4.0 or a <65% reduction in SUVmax in either the primary tumor or lymph node. The Fisher's exact test was used to evaluate factors associated with positive post-treatment PET/ CT values.</p><p><strong>Results: </strong>Sixty-two patients were included for analysis. Median follow-up was 21 months (range: 3-71 months) with a median time to post-treatment PET/CT of 3 months (range: 2-6 months). Median post-treatment SUVmax of the primary disease and nodal disease was 0 (mean: 0.8, range: 0-7.7) and 0 (mean: 0.7, range: 0-9.5), respectively. Median post-treatment percent reduction in SUVmax for the primary site and lymph node was 100% (mean: 94%, range: 31.3-100%) and 100% (mean: 89%, range: 23-100%), respectively. Eleven patients had a positive post-treatment PET/CT with one biopsy-proven recurrence. Negative and positive predictive values (NPV and PPV) were 98% and 9.1%, respectively. There were no factors associated with positive post-treatment PET/CT.</p><p><strong>Conclusion: </strong>Similar to patients treated with photon-based radiation therapy, post-treatment PET/CT has a high NPV for patients with p16+OPC treated with definitive proton therapy and should be used to guide patient management. Additional patients and more events are needed to confirm the PPV of a post-treatment PET/CT in this favorable patient cohort.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f8/1e/JCIS-13-31.PMC10559439.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41130000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypervascular nodular hepatic involvement in multiple myeloma: A case report. 多发性骨髓瘤并发高血管结节性肝损害1例报告。
IF 0.9 Q3 Medicine Pub Date : 2023-09-27 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_60_2023
Yeong Ju Han, Mihyun Park

Multiple myeloma (MM) presenting as multiple hypervascular nodular hepatic infiltration is rare. We report a case of liver involvement of MM in 62-year-old woman presenting as multiple hepatic nodules with arterial enhancement and delayed washout. As in our case, the inclusion of MM in the differential diagnosis of multiple hypervascular hepatic nodules should be considered despite of its rarity.

多发性骨髓瘤(MM)表现为多发性高血管结节性肝浸润是罕见的。我们报告了一例62岁女性多发性骨髓瘤的肝脏受累病例,表现为多发性肝结节,伴有动脉强化和延迟冲洗。与我们的情况一样,尽管MM罕见,但在多发性高血管性肝结节的鉴别诊断中应考虑将其纳入其中。
{"title":"Hypervascular nodular hepatic involvement in multiple myeloma: A case report.","authors":"Yeong Ju Han,&nbsp;Mihyun Park","doi":"10.25259/JCIS_60_2023","DOIUrl":"10.25259/JCIS_60_2023","url":null,"abstract":"<p><p>Multiple myeloma (MM) presenting as multiple hypervascular nodular hepatic infiltration is rare. We report a case of liver involvement of MM in 62-year-old woman presenting as multiple hepatic nodules with arterial enhancement and delayed washout. As in our case, the inclusion of MM in the differential diagnosis of multiple hypervascular hepatic nodules should be considered despite of its rarity.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fe/8c/JCIS-13-29.PMC10559554.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41146174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality assurance for magnetic resonance angiography of the chest in patients suspected of pulmonary embolism during iodinated contrast shortage in the emergency department setting. 急诊科碘造影剂短缺期间疑似肺栓塞患者胸部磁共振血管造影术的质量保证。
IF 0.9 Q3 Medicine Pub Date : 2023-09-22 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_3_2023
Anmol Singh, Mauricio Hernandez, Luis Fernando Calimano-Ramirez, Kazim Z Gumus, Wanda Marfori, Joanna W Kee-Sampson, Chandana Lall, Dheeraj R Gopireddy

Objectives: COVID-19 lockdowns resulted in a global shortage of iodinated contrast media. Therefore, alternative imaging protocols were devised to evaluate patients arriving to the emergency department (ED) with suspicion of pulmonary embolism (PE). This quality assurance (QA) aims to compare diagnostic potential between alternative magnetic resonance angiography (MRA) protocol over the gold standard computed tomography angiography (CTA) by evaluating MRA imaging quality, scanner type/imaging sequence, and any risk of misdiagnosis in patients with symptoms of PE.

Material and methods: This retrospective study compromised of 55 patients who arrived to ED and underwent MRA of the chest for suspicion of PE during the months of May to June 2022. Data regarding their chief complaints, imaging sequence, and MRA results were collected. Two fellowship-trained faculty radiologists reviewed the MRA scans of the patients and scored the quality using a Likert scale.

Results: Two patients were positive for PE and 53 patients showed negative results. Regarding the scan quality issues, motion was noted in 80% of the 55 studies that we reviewed. Significant associations (P < 0.009) between Likert scale scores and initial complaint category were found. The characteristic symptoms associated with suspicion of PE, namely, shortness of breath, chest pain, and cough were distributed among the 1 and 2 categories, reflecting the most optimal vessel opacification scores. We found no risk of misdiagnosis after reviewing the electronic medical record for follow-up appointments within 6 months of ED visit.

Conclusion: Patients were screened for PE with MRA as an alternative imaging tool during times of contrast shortage. Further, evaluation of MRA with CTA, side by side, in a larger patient population is required to increase the validity of our QA study.

目标:新冠肺炎封锁导致全球碘化造影剂短缺。因此,设计了替代成像方案来评估怀疑肺栓塞(PE)而到达急诊科(ED)的患者。该质量保证(QA)旨在通过评估MRA成像质量、扫描仪类型/成像序列、磁共振血管造影(MRA)方案与金标准计算机断层扫描血管造影(CTA)之间的诊断潜力,以及有PE症状的患者的任何误诊风险。材料和方法:这项回顾性研究对2022年5月至6月期间因怀疑PE而到达急诊室并接受胸部MRA的55名患者进行了评估。收集关于他们的主要主诉、成像序列和MRA结果的数据。两名受过奖学金培训的放射科医生审查了患者的MRA扫描,并使用Likert量表对质量进行评分。结果:PE阳性2例,阴性53例。关于扫描质量问题,在我们回顾的55项研究中,80%的研究都注意到了运动。Likert量表评分与初始投诉类别之间存在显著相关性(P<0.009)。与怀疑PE相关的特征性症状,即呼吸急促、胸痛和咳嗽,分布在1类和2类中,反映了最佳的血管混浊评分。我们在ED就诊6个月内复查了随访预约的电子病历后,没有发现误诊的风险。结论:在造影剂短缺时期,MRA作为一种替代成像工具对患者进行PE筛查。此外,需要在更大的患者群体中同时评估MRA和CTA,以提高我们QA研究的有效性。
{"title":"Quality assurance for magnetic resonance angiography of the chest in patients suspected of pulmonary embolism during iodinated contrast shortage in the emergency department setting.","authors":"Anmol Singh,&nbsp;Mauricio Hernandez,&nbsp;Luis Fernando Calimano-Ramirez,&nbsp;Kazim Z Gumus,&nbsp;Wanda Marfori,&nbsp;Joanna W Kee-Sampson,&nbsp;Chandana Lall,&nbsp;Dheeraj R Gopireddy","doi":"10.25259/JCIS_3_2023","DOIUrl":"10.25259/JCIS_3_2023","url":null,"abstract":"<p><strong>Objectives: </strong>COVID-19 lockdowns resulted in a global shortage of iodinated contrast media. Therefore, alternative imaging protocols were devised to evaluate patients arriving to the emergency department (ED) with suspicion of pulmonary embolism (PE). This quality assurance (QA) aims to compare diagnostic potential between alternative magnetic resonance angiography (MRA) protocol over the gold standard computed tomography angiography (CTA) by evaluating MRA imaging quality, scanner type/imaging sequence, and any risk of misdiagnosis in patients with symptoms of PE.</p><p><strong>Material and methods: </strong>This retrospective study compromised of 55 patients who arrived to ED and underwent MRA of the chest for suspicion of PE during the months of May to June 2022. Data regarding their chief complaints, imaging sequence, and MRA results were collected. Two fellowship-trained faculty radiologists reviewed the MRA scans of the patients and scored the quality using a Likert scale.</p><p><strong>Results: </strong>Two patients were positive for PE and 53 patients showed negative results. Regarding the scan quality issues, motion was noted in 80% of the 55 studies that we reviewed. Significant associations (<i>P</i> < 0.009) between Likert scale scores and initial complaint category were found. The characteristic symptoms associated with suspicion of PE, namely, shortness of breath, chest pain, and cough were distributed among the 1 and 2 categories, reflecting the most optimal vessel opacification scores. We found no risk of misdiagnosis after reviewing the electronic medical record for follow-up appointments within 6 months of ED visit.</p><p><strong>Conclusion: </strong>Patients were screened for PE with MRA as an alternative imaging tool during times of contrast shortage. Further, evaluation of MRA with CTA, side by side, in a larger patient population is required to increase the validity of our QA study.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ea/93/JCIS-13-28.PMC10559390.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41134120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral stent-graft for the management of an ulnar artery pseudoaneurysm. 外周支架移植治疗尺动脉假性动脉瘤。
IF 0.9 Q3 Medicine Pub Date : 2023-09-13 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_80_2023
Shivam Khatri, Steven Epstein, Simon Kashfi

Penetrating injury can cause pseudoaneurysm which can then affect nerve compression. Although rare, penetrating injuries leading to ulnar artery pseudoaneurysm (UAP) are implicated slightly more frequently than other upper extremity arterial segments. Manual compression, thrombin injections, and surgical reconstruction are typically chosen to effect repair. Conversely, peripheral stent-graft implantation has rarely been reported as an option to exclude upper extremity pseudoaneurysm. We describe a case of a 25-year-old male who was stabbed, presented with signs of ulnar nerve compression, and in whom UAP was instead discovered and treated by stent-graft deployment.

穿透性损伤可导致假性动脉瘤,进而影响神经压迫。虽然很罕见,但导致尺动脉假性动脉瘤(UAP)的穿透性损伤比其他上肢动脉段更常见。通常选择手动按压、凝血酶注射和外科重建来实现修复。相反,外周支架移植物植入术很少被报道为排除上肢假性动脉瘤的一种选择。我们描述了一个25岁男性的病例,他被刺伤,出现尺神经压迫的迹象,而在这个病例中,UAP被发现并通过支架移植物部署进行治疗。
{"title":"Peripheral stent-graft for the management of an ulnar artery pseudoaneurysm.","authors":"Shivam Khatri,&nbsp;Steven Epstein,&nbsp;Simon Kashfi","doi":"10.25259/JCIS_80_2023","DOIUrl":"10.25259/JCIS_80_2023","url":null,"abstract":"<p><p>Penetrating injury can cause pseudoaneurysm which can then affect nerve compression. Although rare, penetrating injuries leading to ulnar artery pseudoaneurysm (UAP) are implicated slightly more frequently than other upper extremity arterial segments. Manual compression, thrombin injections, and surgical reconstruction are typically chosen to effect repair. Conversely, peripheral stent-graft implantation has rarely been reported as an option to exclude upper extremity pseudoaneurysm. We describe a case of a 25-year-old male who was stabbed, presented with signs of ulnar nerve compression, and in whom UAP was instead discovered and treated by stent-graft deployment.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/10/JCIS-13-27.PMC10559374.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41118236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications with the use of Angio-Seal vascular closure device and their management. 使用Angio-Seal血管封堵器的并发症及其处理。
IF 0.9 Q3 Medicine Pub Date : 2023-09-13 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_68_2023
Mohd Shariq, Krishna Prasad Bellam Premnath, Ahmed Tarek Saleh, Julian Coker

Vascular closure devices (VCDs) are being increasingly used for achieving hemostasis after diagnostic and therapeutic endovascular procedures. Although uncommon, complications may be encountered which are associated with the use of these VCDs. We report four cases where the use of Angio-Seal (Terumo, Somerset, New Jersey, USA) was followed by complications. Three cases presented with acute limb ischemia, among them, two patients had arterial occlusion at the vascular access site and one patient had embolization of the footplate anchor of the closure device. One case presented with pseudoaneurysm at the common femoral artery access site along with occlusion at origin of the superficial femoral artery. We have described the mechanism in which these complications occur and the successful management of these cases preventing potential amputation and limb loss. The risk factors which increase the risk of complications with the use of Angio-Seal VCD were reviewed and the strategy to avoid these complications with particular emphasis on the utility of ultrasound when using Angio-Seal VCD is discussed. A strategy to manage these complications has been discussed while deciding on endovascular management or surgical management, especially in patients with challenging presentation and those with multiple comorbidities making them at very high risk for surgery.

血管闭合装置(VCD)越来越多地用于在诊断和治疗血管内手术后实现止血。虽然不常见,但可能会遇到与使用这些VCD相关的并发症。我们报告了四例使用Angio-Seal(Terumo,Somerset,New Jersey,USA)后出现并发症的病例。3例患者出现急性肢体缺血,其中2例患者血管进入部位动脉闭塞,1例患者对闭合装置的脚板锚钉进行了栓塞。一例在股总动脉入路部位出现假性动脉瘤,并在股浅动脉起点出现闭塞。我们已经描述了这些并发症发生的机制,以及这些病例的成功管理,防止了潜在的截肢和肢体损失。综述了使用Angio-Seal VCD增加并发症风险的风险因素,并讨论了避免这些并发症的策略,特别强调了使用Angio Seal VCD时超声的实用性。在决定血管内治疗或手术治疗时,已经讨论了处理这些并发症的策略,特别是对于表现具有挑战性的患者和患有多种合并症的患者,这些患者的手术风险非常高。
{"title":"Complications with the use of Angio-Seal vascular closure device and their management.","authors":"Mohd Shariq,&nbsp;Krishna Prasad Bellam Premnath,&nbsp;Ahmed Tarek Saleh,&nbsp;Julian Coker","doi":"10.25259/JCIS_68_2023","DOIUrl":"10.25259/JCIS_68_2023","url":null,"abstract":"<p><p>Vascular closure devices (VCDs) are being increasingly used for achieving hemostasis after diagnostic and therapeutic endovascular procedures. Although uncommon, complications may be encountered which are associated with the use of these VCDs. We report four cases where the use of Angio-Seal (Terumo, Somerset, New Jersey, USA) was followed by complications. Three cases presented with acute limb ischemia, among them, two patients had arterial occlusion at the vascular access site and one patient had embolization of the footplate anchor of the closure device. One case presented with pseudoaneurysm at the common femoral artery access site along with occlusion at origin of the superficial femoral artery. We have described the mechanism in which these complications occur and the successful management of these cases preventing potential amputation and limb loss. The risk factors which increase the risk of complications with the use of Angio-Seal VCD were reviewed and the strategy to avoid these complications with particular emphasis on the utility of ultrasound when using Angio-Seal VCD is discussed. A strategy to manage these complications has been discussed while deciding on endovascular management or surgical management, especially in patients with challenging presentation and those with multiple comorbidities making them at very high risk for surgery.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/71/10/JCIS-13-26.PMC10559466.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41115432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of balloon-assisted versus dilator in percutaneous gastrostomy tube placement. 球囊辅助与扩张器在经皮胃造瘘管置入术中的比较。
IF 0.9 Q3 Medicine Pub Date : 2023-09-04 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_55_2023
Sean Lee, Abheek Ghosh, Aislynn Raymond, Nabeel M Akhter

Objectives: This study assesses the safety and efficacy of balloon-assisted gastrostomy (BAG) compared to conventional techniques using dilators.

Material and methods: A single-center retrospective review of all fluoroscopically-guided percutaneous gastrostomy tube insertions from July 2017 to September 2020 was performed. Two hundred and seventy-three patients were included in this study, with 183 patients and 90 patients in the BAG and dilator groups, respectively. Fluoroscopy time, peak radiation dose, pain management, days to interventional radiology (IR) reconsultation, and post-operative complications (major and minor) for each procedure were reviewed to evaluate for statistical differences.

Results: There were shorter fluoroscopy times (5.13 min vs. 7.05 min, P = 0.059) and a significantly lower radiation use (Avg = 102.13 mGy vs. 146.98 mGy, P < 0.05) in the BAG group. The BAG group required significantly lower operating time (41 min vs. 48 min, P < 0.01) and received lower pain management (fentanyl 75 mcg and midazolam 1.5 mg, P < 0.001). The mean days to IR reconsultation for the BAG group was greater (29 days vs. 26 days, P = 0.38). The overall rate of minor complications (grades 1 and 2, according to the CIRSE classification system) was higher in the dilator group (39% vs. 35% in BAG group, P = 0.53). No major complications were reported in either group.

Conclusion: BAG is a safe and efficient technique for percutaneous gastrostomy tube placement. BAG patients required significantly lesser radiation, OR time, post-operative pain management, and recorded lower postoperative complications compared to their counterparts in gastrostomies utilizing dilators.

目的:与使用扩张器的传统技术相比,本研究评估了球囊辅助胃造口术(BAG)的安全性和有效性。材料和方法:对2017年7月至2020年9月所有荧光镜引导下经皮胃造瘘管插入进行单中心回顾性审查。这项研究包括273名患者,BAG组和扩张器组分别有183名患者和90名患者。回顾了每种手术的荧光镜检查时间、峰值辐射剂量、疼痛管理、介入放射学(IR)再咨询的天数以及术后并发症(主要和次要),以评估统计差异。结果:BAG组的荧光透视时间更短(5.13分钟vs.7.05分钟,P=0.059),辐射使用量显著降低(Avg=102.13 mGyvs.146.98 mGy,P<0.05)。BAG组需要的手术时间明显较短(41分钟vs.48分钟,P<0.01),接受的疼痛管理也较低(芬太尼75 mcg和咪唑安定1.5 mg,P<0.001)。BAG组IR再咨询的平均天数更长(29天vs.26天,P=0.038)扩张器组(39%对BAG组的35%,P=0.53)。两组均未报告重大并发症。结论:BAG是一种安全有效的经皮胃造瘘管置入术。与使用扩张器的胃造口患者相比,BAG患者需要更少的辐射、OR时间、术后疼痛管理,并记录了更低的术后并发症。
{"title":"A comparison of balloon-assisted versus dilator in percutaneous gastrostomy tube placement.","authors":"Sean Lee,&nbsp;Abheek Ghosh,&nbsp;Aislynn Raymond,&nbsp;Nabeel M Akhter","doi":"10.25259/JCIS_55_2023","DOIUrl":"10.25259/JCIS_55_2023","url":null,"abstract":"<p><strong>Objectives: </strong>This study assesses the safety and efficacy of balloon-assisted gastrostomy (BAG) compared to conventional techniques using dilators.</p><p><strong>Material and methods: </strong>A single-center retrospective review of all fluoroscopically-guided percutaneous gastrostomy tube insertions from July 2017 to September 2020 was performed. Two hundred and seventy-three patients were included in this study, with 183 patients and 90 patients in the BAG and dilator groups, respectively. Fluoroscopy time, peak radiation dose, pain management, days to interventional radiology (IR) reconsultation, and post-operative complications (major and minor) for each procedure were reviewed to evaluate for statistical differences.</p><p><strong>Results: </strong>There were shorter fluoroscopy times (5.13 min vs. 7.05 min, <i>P</i> = 0.059) and a significantly lower radiation use (Avg = 102.13 mGy vs. 146.98 mGy, <i>P</i> < 0.05) in the BAG group. The BAG group required significantly lower operating time (41 min vs. 48 min, <i>P</i> < 0.01) and received lower pain management (fentanyl 75 mcg and midazolam 1.5 mg, <i>P</i> < 0.001). The mean days to IR reconsultation for the BAG group was greater (29 days vs. 26 days, <i>P</i> = 0.38). The overall rate of minor complications (grades 1 and 2, according to the CIRSE classification system) was higher in the dilator group (39% vs. 35% in BAG group, <i>P</i> = 0.53). No major complications were reported in either group.</p><p><strong>Conclusion: </strong>BAG is a safe and efficient technique for percutaneous gastrostomy tube placement. BAG patients required significantly lesser radiation, OR time, post-operative pain management, and recorded lower postoperative complications compared to their counterparts in gastrostomies utilizing dilators.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/06/JCIS-13-25.PMC10559364.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41128267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imaging of penetrating vascular trauma of the body and extremities secondary to ballistic and stab wounds. 继发于弹道伤和刺伤的身体和四肢穿透性血管创伤的成像。
IF 1.1 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-01-03 eCollection Date: 2023-01-01 DOI: 10.25259/JCIS_99_2022
Dheeraj Reddy Gopireddy, Joanna W Kee-Sampson, Sai Swarupa Reddy Vulasala, Rachel Stein, Sindhu Kumar, Mayur Virarkar

In the United States, gunshot wounds (GSWs) have become a critical public health concern with substantial annual morbidity, disability, and mortality. Vascular injuries associated with GSW may pose a clinical challenge to the physicians in the emergency department. Patients demonstrating hard signs require immediate intervention, whereas patients with soft signs can undergo further diagnostic testing for better injury delineation. Although digital subtraction angiography is the gold standard modality to assess vascular injuries, non-invasive techniques such as Doppler ultrasound, computed tomography angiography, and magnetic resonance angiography have evolved as appropriate alternatives. This article discusses penetrating bodily vascular injuries, specifically ballistic and stab wounds, and the corresponding radiological presentations.

在美国,枪伤(GSW)已成为一个严重的公共卫生问题,每年都会造成大量的发病、残疾和死亡。与枪伤相关的血管损伤可能会给急诊科医生带来临床挑战。有硬性体征的患者需要立即进行干预,而有软性体征的患者则可以接受进一步的诊断检查,以便更好地确定损伤部位。虽然数字减影血管造影术是评估血管损伤的金标准模式,但多普勒超声、计算机断层扫描血管造影术和磁共振血管造影术等非侵入性技术已发展成为合适的替代方法。本文将讨论穿透性身体血管损伤,特别是弹道伤和刺伤,以及相应的放射学表现。
{"title":"Imaging of penetrating vascular trauma of the body and extremities secondary to ballistic and stab wounds.","authors":"Dheeraj Reddy Gopireddy, Joanna W Kee-Sampson, Sai Swarupa Reddy Vulasala, Rachel Stein, Sindhu Kumar, Mayur Virarkar","doi":"10.25259/JCIS_99_2022","DOIUrl":"10.25259/JCIS_99_2022","url":null,"abstract":"<p><p>In the United States, gunshot wounds (GSWs) have become a critical public health concern with substantial annual morbidity, disability, and mortality. Vascular injuries associated with GSW may pose a clinical challenge to the physicians in the emergency department. Patients demonstrating hard signs require immediate intervention, whereas patients with soft signs can undergo further diagnostic testing for better injury delineation. Although digital subtraction angiography is the gold standard modality to assess vascular injuries, non-invasive techniques such as Doppler ultrasound, computed tomography angiography, and magnetic resonance angiography have evolved as appropriate alternatives. This article discusses penetrating bodily vascular injuries, specifically ballistic and stab wounds, and the corresponding radiological presentations.</p>","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/25/66/JCIS-13-1.PMC9899476.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9244000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Imaging Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1